Glucagon also stimulates GLP-1 receptors, though, to a lesser extent than its primary ligand (25), that has been proven beneficial in the treatment of both diabetes and obesity. The gene discussed is GLP1R; the disease is obesity due to melanocortin 4 receptor deficiency.